Short summary

Liver transplantation is the only curative treatment for patients with end-stage liver disease. In Denmark, more than 600 patients live with a transplanted liver. However, the long-term survival is poor. Cardiovascular diseases (CVD) are common complications post-transplantation and contribute to mortality. To improve long-term survival, information about the incidence, risk factors, and pathogenesis of CVD is needed. HYPOTHESIS The incidence of CVD in liver transplant recipients is higher.

Rationale

This study aims to determine

- Whether the prevalence of CVD including coronary artery disease, electrophysiological abnormalities, and cardiac dysfunction in liver transplant recipients is different from that in the general population.

- Whether liver transplantation or liver graft function are independent risk factors for

Description of the cohort

Livertransplanted patients from department of hepatology, OUH

Data and biological material

Blood

Collaborating researchers and departments

Rigshospitalet

Infectious and surgical department